使用NIHR方法评估法国学术临床试验的碳足迹
Cécile Auriault1, Martine Tching-Sin2, Laetitia Biron3
1Pharmacy, CHU Nantes, Nantes, Pays de la Loire, France cecile.auriault@hotmail.fr.
BMJ open
|December 26, 2025
概括
国家卫生和护理研究所 (NIHR) 的工具有效评估了法国的临床试验,确定了旅行和临床单位的排放作为关键的碳热点. 这些试验显示环境影响低于预期,并确定了未来减缓的领域.
科学领域:
- 临床研究中的环境影响评估.
- 绿色医疗保健和可持续的临床试验
- 学术研究的碳足迹分析
背景情况:
- 评估临床试验对环境的影响对于可持续的医疗保健至关重要.
- 国家卫生和护理研究所 (NIHR) 的工具为碳足迹评估提供了一个框架.
- 现有的环境评估工具对各种研究环境的适用性需要验证.
研究的目的:
- 评估NIHR工具对法国学术临床研究的适用性.
- 在两个不同的临床试验中识别碳热点.
- 探索潜在的策略,以减轻临床研究对环境的影响.
主要方法:
- 两项已完成的临床试验的回顾性分析:TOCILAM (第一阶段,血液学) 和REMICRUSH (第三阶段,重症监护).
- 使用NIHR工具计算每项研究的总碳排放量 (二氧化碳相当量).
- 确定了碳足迹的主要贡献者,称为"热点".
主要成果:
- 托西拉姆的碳足迹为3.2二氧化碳等价物,而雷米克鲁什的碳足迹为5.8二氧化碳等价物.
- 确定的主要碳热点是"会议和旅行"和"临床试验单位排放".
- 这些试验的总体碳足迹发现低于之前报告的类似学术研究.
结论:
- 该NIHR工具很容易适用于法国学术临床研究.
- 虽然评估的试验的碳足迹相对较低,但需要注意的具体领域是减少对环境的影响.
- 建议进一步研究和实施缓解策略,以提高临床试验的可持续性.
更多相关视频
07:52Expired CO2 Measurement in Intubated or Spontaneously Breathing Patients from the Emergency Department
Published on: January 29, 2011
16.7K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
相关概念视频
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
376
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
376
Bioavailability Study Design: Healthy Subjects Versus Patients
130
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
130
